Skip to content
CPV 33696500Closed

Italy – Laboratory reagents – Procedura aperta ai sensi dell'art.71 del D.lgs.n.36/2023 in modalità telematica Application Service Provider (ASP) per la fornitura in somministrazione per anni quattro di reattivi per analisi in NGS con sequenziamento ad alta produttività per esoma clinico pannello cancer GPC e pannelli di resequencing dedicati e/o compatibili per strumentazione Nextseq550DX e MiseQdx per la UOSD Genetica Medica

Italia – Reattivi per laboratorio – Procedura aperta ai sensi dell'art.71 del D.lgs.n.36/2023 in modalità telematica Application Service Provider (ASP) per la fornitura in somministrazione per anni quattro di reattivi per analisi in NGS con sequenziamento ad alta produttività per esoma clinico pannello cancer GPC e pannelli di resequencing dedicati e/o compatibili per strumentazione Nextseq550DX e MiseQdx per la UOSD Genetica Medica · Original title, Italian

Buyer: Grande Ospedale Metropolitano di Reggio Calabria

  • Supplies to a defence buyer
  • Health body
  • Dual-use / security

Classified automatically; see how

Only the buyer is a defence body; the notice itself is not marked as defence.

Deadline3 Mar 2026, 12:00 UTC
Estimated value
EUR 1,550,000
Estimated
Notice ID
62266-2026
Published
Procedure
Open procedure
Legal basis
32014L0024
Directive 2014/24/EU (public procurement)
Buyer country
ITItaly
Security clearance
Not indicated
Subcontracting
Not indicated
Lots
2

CPV codes

  • 33696500MainMedical equipments, pharmaceuticals and personal care products (group)
  • 35331500Weapons, ammunition and associated parts (group)

Version history

Every change we observe is stored as a new version. Earlier versions are never overwritten or deleted. One version observed so far.

  1. Version 1 · Detected First observed by DefenceGate

Source and attribution

Source
Tenders Electronic Daily
Retrieved
Licence
Commission Decision 2011/833/EU; notices freely reusable incl. commercial
Attribution
Source: TED (Tenders Electronic Daily), © European Union
View original (opens in new tab)